| Literature DB >> 27574102 |
Xinyi Wang1,2, Na Wang1,3, Lan Yuan1, Na Li4, Junxia Wang5, Xiaoda Yang1.
Abstract
Tight junctions play a key role in restricting or regulating passage of liquids, ions and large solutes through various biological barriers by the paracellular route. Changes in paracellular permeation indicate alteration of the tight junction. However, it is very difficult to obtain the structural change information by measuring paracellular flux based on transepithelial electrical resistance or usingEntities:
Year: 2016 PMID: 27574102 PMCID: PMC5004201 DOI: 10.1038/srep32218
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1TEM images of AuNC@GSH (A) and AuNC@BSA (C). Insets display thelattice fringe of an individual nanocluster. Histograms of (B) and (D) show the size distribution of AuNC@GSH and AuNC@BSA obtained from corresponding TEM image, respectively.
Some physicochemical parameters of Eu-DTPA and AuNC probes.
| Parameters | Eu-DTPA | AuNC@GSH | AuNC@BSA |
|---|---|---|---|
| MA (g/mol) | 560.54 | 1.4 × 104 | 7.1 × 104 |
| Particle core diameter (nm) (TEM) | — | 2.1 ± 0.5 | 2.0 ± 0.4 |
| Volume weighted hydrodynamic diameter (nm) | 0.902 | 6.0 ± 1.03 | 12.1 ± 0.33 |
| ζ potential (mV) | — | −1.47 ± 4.96 | −7.89 ± 4.38 |
| 3.36 × 10−10 | 1.15 × 10−10 | 6.68 × 10−11 |
1Parameters calculated using the Polson’s equation: whereVA is the volume of solute probe; μB and MB are the viscosity and molar mass of the solvent water, respectively; T is the absolute temperature.
2The diameter of Eu-DTPA was calculated using HyperChem software.
3Data were from DLS measurement (Figure S5).
Figure 2MTS assays of MDCK cells upon treatment with AuNCs and Eu-DTPA.
(A) AuNC@BSA. (B) AuNC@GSH. (C) Eu-DTPA. (D) AuNC@BSA + Eu-DTPA. (E) AuNC@GSH + Eu-DTPA. C-1 denotes combination of 20 μmol/L Eu-DTPA with 1 mg/mL AuNC@BSA or 0.8 mg/mL AuNC@GSH, and C-2∼C-8 denote proportional dilution of C-1. (F) TEER of MDCK cell monolayer after treated with AuNCs and Eu-DTPA combination at C-1 concentration. All data were the mean ± SD of four replicates.
Figure 3Rates of cellular accumulation of AuNCs in MDCK cells.
The incubated time was 6 h at 37 °C (10% FBS) and 25 °C (free FBS), respectively.
Figure 4Confocal images of AuNCs in TJs of MDCK layers after EDTA treatment (0.5 mmol/L) for 30 min at 25 °C.
The concentrations of AuNCs were 1 mg/mL for AuNC@BSA (A) and 0.8 mg/mL for AuNC@GSH (B). Ch1 denote cell autofluorescence with λEx/Em of 488/520 nm.
Figure 5The time course of membrane permeation of double fluorescent probes in absence (black line) and presence (red line) of EDTA treatment (0.5 mmol/L).
A and B are the permeability of Eu-DTPA (A) and AuNC@BSA (B) in the Eu-DTPA (20 μmol/L)−AuNC@BSA (1 mg/mL) probe system, respectively; C and D are the permeability of Eu-DTPA (C) and AuNC@GSH (D) in the Eu-DTPA (20 μmol/L)−AuNC@GSH (0.8 mg/mL) probe system, respectively. Data were the mean ± SD of three replicates.
Figure 6The time course of membrane permeation of double fluorescent probes in absence (black line) and presence (red line) of vanadyl complexes (80 μmol/L).
A and B are the permeability of Eu-DTPA (A) and AuNC@BSA (B) in the Eu-DTPA (20 μmol/L)−AuNC@BSA (1 mg/mL) probe system, respectively; C and D are the permeability of Eu-DTPA (C) and AulNC@GSH (D) in the Eu-DTPA (20 μmol/L)−AuNC@GSH (0.8 mg/mL) probe system, respectively. Data were the mean ± SD of three replicates.
Figure 7Alteration of tight junction pore size, r (left column) and retention capacity, ε/τ (right column) calculated by use of Eu-DTPA/AuNC@BSA probes (A,B) and Eu-DTPA/AuNC@GSH (C,D) probes upon EDTA treatment, and Eu-DTPA/AuNC@GSH (E,F) probe upon vanadium treatment.